Clinical Trial Update: A Study for Patients With Non-Hodgkin's Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 trial update for a study in non-Hodgkin's lymphomas has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Non-hodgkin Lymphoma
• T-cell Lymphoma

Snippet

Sponsor: Eli Lilly and Company | Conditions: T-Cell Lymphoma, B-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19